Christine A Cabelka1, Cory W Baumann1, Brittany C Collins1, Nardina Nash1, Gengyun Le1, Angus Lindsay2, Espen E Spangenburg3, Dawn A Lowe4. 1. Divisions of Rehabilitation Science and Physical Therapy, Department of Rehabilitation Medicine, Medical School, University of Minnesota, Minneapolis, Minnesota; MMC 388, 420 Delaware St SE, Minneapolis, MN 55455, USA. 2. Divisions of Rehabilitation Science and Physical Therapy, Department of Rehabilitation Medicine, Medical School, University of Minnesota, Minneapolis, Minnesota; MMC 388, 420 Delaware St SE, Minneapolis, MN 55455, USA; Department of Biochemistry Molecular Biology and Biophysics, University of Minnesota, 420 Washington Ave SE, Minneapolis, MN 55455, USA. 3. East Carolina Diabetes and Obesity Institute, Department of Physiology, Brody School of Medicine, East Carolina University, 115 Heart Drive, ECHI - Mail Stop 743, Greenville, NC 27834, USA. 4. Divisions of Rehabilitation Science and Physical Therapy, Department of Rehabilitation Medicine, Medical School, University of Minnesota, Minneapolis, Minnesota; MMC 388, 420 Delaware St SE, Minneapolis, MN 55455, USA. Electronic address: lowex017@umn.edu.
Abstract
Menopause is associated with declines in physical activity and skeletal muscle strength. Physical activity is also reduced in rodents after ovariectomy (OVX) and whole-body estrogen receptor α (ERα) knockout. However, it is unclear if the effects are estradiol (E2) specific. Thus, the overall purpose of this study was to investigate the effects of the ovarian hormones, E2 and progesterone (P4), and skeletal muscle ERα (skmERα) on physical activity and skeletal muscle contractility in female mice. METHODS: Study 1: Forty female C57Bl/6J mice were given free access to running wheels for 2 weeks to assess baseline running and randomized into 4 treatment groups: OVX, OVX + E2, OVX + P4, OVX + E2 + P4. All mice underwent OVX, returned to wheels for 2 weeks, received hormone pellet implants and returned to running wheels for 6 weeks, after which soleus muscle contractility testing was completed. Study 2: Thirty-two skeletal muscle specific ERα knock-out (skmERαKO) mice and wildtype (WT) littermates were randomized into 4 groups: skmERαKO-Run, skmERαWT-Run, skmERαKO-Sed, and skmERαWT-Sed. Run mice were given free access to wheels for 20 wk and sedentary (Sed) mice maintained normal cage activities. At the end point, muscle contractility was tested. RESULTS: Study 1: OVX + E2 + P4 group ran greater distances than both the OVX and OVX + P4 groups (p ≤ 0.009). After fatiguing contractions, soleus muscles of the OVX + E2 + P4 group maintained greater submaximal force than those of other groups (p = 0.023). Immediately after the fatiguing contractions, OVX + E2 + P4 muscles had greater maximal force production than the OVX + E2 group (p = 0.027). Study 2: There were no differences in running distance between skmERαWT and skmERαKO mice (p = 0.240). Soleus muscles of skmERαKO mice were more fatigable (p < 0.001) and did not recover force as well as skmERαWT mice (p < 0.001). In vivo isometric, concentric and eccentric torque was decreased in skmERαKO mice compared to skmERαWT mice (p ≤ 0.029). CONCLUSIONS: Combined treatment of E2 + P4 in OVX mice restored physical activity, predominantly driven by E2, and protected soleus muscles against fatigue. Muscle of skmERαKO mice was weak regardless of physical activity. Although 20 wk of wheel running partially prevented force loss during fatigue in skmERαKO mice, force production during recovery remained low, indicating that estradiol functions through ERα in skeletal muscle.
Menopause is associated with declines in physical activity and skeletal muscle strength. Physical activity is also reduced in rodents after ovariectomy (OVX) and whole-body estrogen receptor α (ERα) knockout. However, it is unclear if the effects are estradiol (E2) specific. Thus, the overall purpose of this study was to investigate the effects of the ovarian hormones, E2 and progesterone (P4), and skeletal muscle ERα (skmERα) on physical activity and skeletal muscle contractility in female mice. METHODS: Study 1: Forty female C57Bl/6J mice were given free access to running wheels for 2 weeks to assess baseline running and randomized into 4 treatment groups: OVX, OVX + E2, OVX + P4, OVX + E2 + P4. All mice underwent OVX, returned to wheels for 2 weeks, received hormone pellet implants and returned to running wheels for 6 weeks, after which soleus muscle contractility testing was completed. Study 2: Thirty-two skeletal muscle specific ERα knock-out (skmERαKO) mice and wildtype (WT) littermates were randomized into 4 groups: skmERαKO-Run, skmERαWT-Run, skmERαKO-Sed, and skmERαWT-Sed. Run mice were given free access to wheels for 20 wk and sedentary (Sed) mice maintained normal cage activities. At the end point, muscle contractility was tested. RESULTS: Study 1: OVX + E2 + P4 group ran greater distances than both the OVX and OVX + P4 groups (p ≤ 0.009). After fatiguing contractions, soleus muscles of the OVX + E2 + P4 group maintained greater submaximal force than those of other groups (p = 0.023). Immediately after the fatiguing contractions, OVX + E2 + P4 muscles had greater maximal force production than the OVX + E2 group (p = 0.027). Study 2: There were no differences in running distance between skmERαWT and skmERαKO mice (p = 0.240). Soleus muscles of skmERαKO mice were more fatigable (p < 0.001) and did not recover force as well as skmERαWT mice (p < 0.001). In vivo isometric, concentric and eccentric torque was decreased in skmERαKO mice compared to skmERαWT mice (p ≤ 0.029). CONCLUSIONS: Combined treatment of E2 + P4 in OVX mice restored physical activity, predominantly driven by E2, and protected soleus muscles against fatigue. Muscle of skmERαKO mice was weak regardless of physical activity. Although 20 wk of wheel running partially prevented force loss during fatigue in skmERαKO mice, force production during recovery remained low, indicating that estradiol functions through ERα in skeletal muscle.
Authors: Gordon I Smith; Jun Yoshino; Dominic N Reeds; David Bradley; Rachel E Burrows; Henry D Heisey; Anna C Moseley; Bettina Mittendorfer Journal: J Clin Endocrinol Metab Date: 2013-12-20 Impact factor: 5.958
Authors: Torsten Hertrampf; Gisela H Degen; Abdel Ait Kaid; Ute Laudenbach-Leschowsky; Jan Seibel; Ana Laura Di Virgilio; Patrick Diel Journal: Planta Med Date: 2006-05 Impact factor: 3.352
Authors: Edward L Melanson; Kate Lyden; Ellie Gibbons; Kathleen M Gavin; Pamela Wolfe; Margaret E Wierman; Robert S Schwartz; Wendy M Kohrt Journal: Med Sci Sports Exerc Date: 2018-08 Impact factor: 5.411
Authors: Richard P Troiano; David Berrigan; Kevin W Dodd; Louise C Mâsse; Timothy Tilert; Margaret McDowell Journal: Med Sci Sports Exerc Date: 2008-01 Impact factor: 5.411
Authors: Christine A Cabelka; Cory W Baumann; Angus Lindsay; Andrew Norton; Nick C Blixt; Gengyun Le; Gordon L Warren; Kim C Mansky; Susan A Novotny; Dawn A Lowe Journal: J Endocrinol Date: 2021-02 Impact factor: 4.286
Authors: Hanna-Kaarina Juppi; Sarianna Sipilä; Neil J Cronin; Sira Karvinen; Jari E Karppinen; Tuija H Tammelin; Pauliina Aukee; Vuokko Kovanen; Urho M Kujala; Eija K Laakkonen Journal: J Clin Med Date: 2020-05-23 Impact factor: 4.241
Authors: Kelly N Z Fuller; Colin S McCoin; Julie Allen; Shelby Bell-Glenn; Devin C Koestler; Gerald W Dorn; John P Thyfault Journal: J Appl Physiol (1985) Date: 2020-04-02